A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004

C Zhu, T Zheng, BA Kilfoy, X Han, S Ma, Y Ba, Y Bai… - Thyroid, 2009 - liebertpub.com
… Background: The incidence of papillary thyroid cancer has been … the incidence pattern of
papillary thyroid cancer in the United … of papillary thyroid cancer using the National Cancer

Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases

G Pellegriti, C Scollo, G Lumera… - The Journal of …, 2004 - academic.oup.com
… In conclusion, approximately one of four patients with a papillary thyroid cancer no more
than 1.5 cm in size develops relapsing/persisting disease after surgery. Baseline …

Papillary thyroid cancer

NR Caron, OH Clark - Current treatment options in oncology, 2006 - Springer
thyroid cancer because these malignant cells retain many of the features of the native thyroid
… to produce thyroglobulin, to be stimulated by thyroidstimulating hormone (TSH), and to take …

Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome

JS Radowsky, RS Howard, HB Burch, A Stojadinovic - Thyroid, 2014 - liebertpub.com
Background: The clinical importance of extrathyroidal extension (ETE) on outcome of papillary
thyroid cancer (PTC), particularly with respect to disease extending to the surgical margin …

[HTML][HTML] Recurrence of papillary thyroid cancer after optimized surgery

CS Grant - Gland surgery, 2015 - ncbi.nlm.nih.gov
… Recurrence of papillary thyroid cancer (PTC) after optimized surgery … thyroid nodules that
prove to be papillary thyroid microcarcinomas (PTMC). With rare exception, these cancers are …

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei… - Jama, 2013 - jamanetwork.com
Importance BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its
role in PTC-related patient mortality has not been established. Objective To investigate the …

The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients

CC Lubitz, JA Sosa - Cancer, 2016 - Wiley Online Library
thyroid cancer has tripled over the past 3 decades, with the vast majority of the increase noted
to be among small, indolent papillary thyroid … in the incidence of thyroid cancer is slowing. …

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

M Xing, WH Westra, RP Tufano, Y Cohen… - The Journal of …, 2005 - academic.oup.com
… this BRAF mutation occurs in papillary thyroid cancer (PTC) with a … thyroid cancers but not
in normal thyroid tissue or benign thyroid neoplasms or follicular or medullary thyroid cancers

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells

MD Ringel, E Hardy, VJ Bernet… - The Journal of …, 2002 - academic.oup.com
… in thyroid cancer. We measured metastin and metastin receptor mRNA levels in 10 FCs and
13 papillary … (FAs), and 11 normal thyroid samples, and evaluated the signaling pathways …

Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer

D Ahn, SJ Heo, JH Park, JH Kim, JH Sohn… - Acta …, 2011 - Taylor & Francis
… be diagnosed with thyroid cancer in 2009 [Citation1]. Papillary thyroid cancer (PTC), the
most prevalent manifestation of thyroid cancer, represents 70–80% of all diagnosed thyroid